North America Pharmaceutical Contract Research Organization (CRO) Market 2020-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity

Report ID: 79163 | Published Date: Oct 2024 | No. of Page: 106 | Base Year: 2023 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents
1 Introduction	6
1.1 Industry Definition and Research Scope	6
1.1.1 Industry Definition	6
1.1.2 Research Scope	7
1.2 Research Methodology	10
1.2.1 Overview of Market Research Methodology	10
1.2.2 Market Assumption	11
1.2.3 Secondary Data	11
1.2.4 Primary Data	11
1.2.5 Data Filtration and Model Design	13
1.2.6 Market Size/Share Estimation	14
1.2.7 Research Limitations	15
1.3 Executive Summary	16
2 Market Overview and Dynamics	19
2.1 Market Size and Forecast	19
2.1.1 Impact of COVID-19 on World Economy	20
2.1.2 Impact of COVID-19 on the Market	23
2.2 Major Growth Drivers	25
2.3 Market Restraints and Challenges	30
2.4 Emerging Opportunities and Market Trends	33
2.5 Porter’s Fiver Forces Analysis	37
3 Segmentation of North America Market by Service	41
3.1 Market Overview by Service	41
3.2 CRO for Pre-clinical Development	43
3.3 CRO for Phase I Trials	44
3.4 CRO for Phase II Trials	45
3.5 CRO for Phase III Trials	46
3.6 CRO for Phase IV Trials	47
3.7 Laboratory Services	48
3.8 Consulting Services	49
3.9 Data Management Services	50
4 Segmentation of North America Market by Therapeutic Application	51
4.1 Market Overview by Therapeutic Application	51
4.2 Infectious Diseases	53
4.3 Oncology	54
4.4 Metabolic Disorders	55
4.5 Cardiovascular Disorders	56
4.6 Central Nervous System	57
4.7 Respiratory Disorders	58
4.8 Gastrointestinal Disorders	59
4.9 Other Therapeutic Applications	60
5 Segmentation of North America Market by End User	61
5.1 Market Overview by End User	61
5.2 Pharmaceutical & Biopharmaceutical Companies	63
5.3 Medical Device Companies	64
5.4 Academic Institutes	65
6 North America Market 2019-2030 by Country	67
6.1 Overview of North America Market	67
6.2 U.S.	70
6.3 Canada	74
6.4 Mexico	76
7 Competitive Landscape	78
7.1 Overview of Key Vendors	78
7.2 New Product Launch, Partnership, Investment, and M&A	82
7.3 Company Profiles	83
Charles River Laboratories	83
CMIC Co. Ltd	85
Covance Inc.	86
Hangzhou Tigermed Consulting Co Ltd	87
ICON Plc	88
IQVIA Holdings Inc.	89
LSK North America Pharma Service Co Ltd	90
Novotech Pty Ltd	91
PAREXEL International Corporation	92
Pharmaceutical Product Development LLC (PPD)	93
PRA Health Sciences Inc.	94
Quanticate Ltd	95
Samsung Bioepis Co. Ltd	96
SGS SA (SGS Life Sciences)	97
Syneos Health Inc.	98
WuXi AppTec Inc.	99
8 Investing in North America Market: Risk Assessment and Management	100
8.1 Risk Evaluation of North America Market	100
8.2 Critical Success Factors (CSFs)	103
Related Reports and Products	106
Table 1.  Snapshot of North America Pharmaceutical CRO Market in Balanced Perspective, 2019-2030	17
Table 2. Growth Rate of World Real GDP, 2017-2021	21
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn	27
Table 4. Worldwide Total Number of Registered Clinical Trials	29
Table 5.  Main Product Trends and Market Opportunities in North America Pharmaceutical CRO Market	33
Table 6. North America Pharmaceutical CRO Market by Service, 2019-2030, $ bn	41
Table 7. North America Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn	51
Table 8. North America Pharmaceutical CRO Market by End User, 2019-2030, $ bn	61
Table 9. North America Pharmaceutical CRO Market by Country, 2019-2030, $ bn	68
Table 10. U.S. Pharmaceutical CRO Market by Service, 2019-2030, $ bn	72
Table 11. U.S. Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn	72
Table 12. U.S. Pharmaceutical CRO Market by End User, 2019-2030, $ bn	72
Table 13. Canada Pharmaceutical CRO Market by Service, 2019-2030, $ bn	75
Table 14. Canada Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn	75
Table 15. Canada Pharmaceutical CRO Market by End User, 2019-2030, $ bn	75
Table 16. Mexico Pharmaceutical CRO Market by Service, 2019-2030, $ bn	77
Table 17. Mexico Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn	77
Table 18. Mexico Pharmaceutical CRO Market by End User, 2019-2030, $ bn	77
Table 19. Breakdown of North America Market by Key Vendor, 2019, %	80
Table 20. Charles River Laboratories: Company Snapshot	83
Table 21. Charles River Laboratories: Business Segmentation	83
Table 22. Charles River Laboratories: Product Portfolio	84
Table 23. Charles River Laboratories: Revenue, 2016-2018, $ bn	84
Table 24. Charles River Laboratories: Recent Developments	84
Table 25.  Risk Evaluation for Investing in North America Market, 2019-2030	101
Table 26. Critical Success Factors and Key Takeaways	104
Figure 1. Research Method Flow Chart	10
Figure 2. Breakdown of Primary Research	12
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation	14
Figure 4. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030	16
Figure 5. North America Pharmaceutical CRO Market, 2019-2030, $ bn	19
Figure 6. Impact of COVID-19 on Business	23
Figure 7. Primary Drivers and Impact Factors of North America Pharmaceutical CRO Market	25
Figure 8. Primary Restraints and Impact Factors of North America Pharmaceutical CRO Market	30
Figure 9. Investment Opportunity Analysis	34
Figure 10. Porter’s Fiver Forces Analysis of North America Pharmaceutical CRO Market	37
Figure 11. Breakdown of North America Pharmaceutical CRO Market by Service, 2019-2030, % of Sales Revenue	42
Figure 12. North America Addressable Market Cap in 2020-2030 by Service, Value ($ bn) and Share (%)	42
Figure 13. North America Pharmaceutical CRO Market: CRO for Pre-clinical Development, 2019-2030, $ bn	43
Figure 14. North America Pharmaceutical CRO Market: CRO for Phase I Trials, 2019-2030, $ bn	44
Figure 15. North America Pharmaceutical CRO Market: CRO for Phase II Trials, 2019-2030, $ bn	45
Figure 16. North America Pharmaceutical CRO Market: CRO for Phase III Trials, 2019-2030, $ bn	46
Figure 17. North America Pharmaceutical CRO Market: CRO for Phase IV Trials, 2019-2030, $ bn	47
Figure 18. North America Pharmaceutical CRO Market: Laboratory Services, 2019-2030, $ bn	48
Figure 19. North America Pharmaceutical CRO Market: Consulting Services, 2019-2030, $ bn	49
Figure 20. North America Pharmaceutical CRO Market: Data Management Services, 2019-2030, $ bn	50
Figure 21. Breakdown of North America Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, % of Sales Revenue	52
Figure 22. North America Addressable Market Cap in 2020-2030 by Therapeutic Application, Value ($ bn) and Share (%)	52
Figure 23. North America Pharmaceutical CRO Market: Infectious Diseases, 2019-2030, $ bn	53
Figure 24. North America Pharmaceutical CRO Market: Oncology, 2019-2030, $ bn	54
Figure 25. North America Pharmaceutical CRO Market: Metabolic Disorders, 2019-2030, $ bn	55
Figure 26. North America Pharmaceutical CRO Market: Cardiovascular Disorders, 2019-2030, $ bn	56
Figure 27. North America Pharmaceutical CRO Market: Central Nervous System, 2019-2030, $ bn	57
Figure 28. North America Pharmaceutical CRO Market: Respiratory Disorders, 2019-2030, $ bn	58
Figure 29. North America Pharmaceutical CRO Market: Gastrointestinal Disorders, 2019-2030, $ bn	59
Figure 30. North America Pharmaceutical CRO Market: Other Therapeutic Applications, 2019-2030, $ bn	60
Figure 31. Breakdown of North America Pharmaceutical CRO Market by End User, 2019-2030, % of Revenue	62
Figure 32. North America Addressable Market Cap in 2020-2030 by End User, Value ($ bn) and Share (%)	62
Figure 33. North America Pharmaceutical CRO Market: Pharmaceutical & Biopharmaceutical Companies, 2019-2030, $ bn	63
Figure 34. North America Pharmaceutical CRO Market: Medical Device Companies, 2019-2030, $ bn	64
Figure 35. North America Pharmaceutical CRO Market: Academic Institutes, 2019-2030, $ bn	65
Figure 36. Breakdown of North America Pharmaceutical CRO Market by Country, 2019 and 2030, % of Revenue	68
Figure 37. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)	69
Figure 38. U.S. Pharmaceutical CRO Market, 2019-2030, $ bn	71
Figure 39. Canada Pharmaceutical CRO Market, 2019-2030, $ bn	74
Figure 40.  Pharmaceutical CRO Market in Mexico, 2015-2030, $ bn	76
Figure 41. Growth Stage of North America Pharmaceutical CRO Industry over the Forecast Period	78
Companies Included in Reports:
Key Players (this may not be a complete list and extra companies can be added upon request): 
Charles River Laboratories	
CMIC Co. Ltd	
Covance Inc.	
Hangzhou Tigermed Consulting Co Ltd	
ICON Plc	
IQVIA Holdings Inc.	
LSK Global Pharma Service Co Ltd	
Novotech Pty Ltd	
PAREXEL International Corporation	
Pharmaceutical Product Development LLC (PPD)	
PRA Health Sciences Inc.	
Quanticate Ltd	
Samsung Bioepis Co. Ltd	
SGS SA (SGS Life Sciences)	
Syneos Health Inc.	
WuXi AppTec Inc.
Frequently Asked Questions
North America Pharmaceutical Contract Research Organization Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
North America Pharmaceutical Contract Research Organization Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
North America Pharmaceutical Contract Research Organization Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports